Thomas V. Riera, Ph.D.
Affiliations: | 2007 | Biochemistry | Brandeis University, Waltham, MA, United States |
Area:
BiochemistryGoogle:
"Thomas Riera"Parents
Sign in to add mentor| Lizbeth Hedstrom | grad student | 2007 | Brandeis | |
| (Thermodynamic and kinetic consequences of conformational changes in IMP dehydrogenase catalysis: Characterization of flap mutants and potassium activation.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Thomenius MJ, Totman J, Harvey D, et al. (2018) Small molecule inhibitors and CRISPR/Cas9 mutagenesis demonstrate that SMYD2 and SMYD3 activity are dispensable for autonomous cancer cell proliferation. Plos One. 13: e0197372 |
| Thomenius MJ, Totman J, Cosmopoulos K, et al. (2018) Identification of a First-in-Class SETD2 Inhibitor That Shows Potent and Selective Anti-Proliferative Activity in t(4;14) Multiple Myeloma: T(4;14) Multiple Myeloma Cells Are Dependent on Both H3K36 Di and Tri-Methylation Blood. 132: 3207-3207 |
| Drew AE, Moradei O, Jacques SL, et al. (2017) Identification of a CARM1 Inhibitor with Potent In Vitro and In Vivo Activity in Preclinical Models of Multiple Myeloma. Scientific Reports. 7: 17993 |
| Riera TV, Wigle TJ, Copeland RA. (2016) Characterization of Inhibitor Binding Through Multiple Inhibitor Analysis: A Novel Local Fitting Method. Methods in Molecular Biology (Clifton, N.J.). 1439: 33-45 |
| Jacques SL, Aquino KP, Gureasko J, et al. (2016) CARM1 Preferentially Methylates H3R17 over H3R26 through a Random Kinetic Mechanism. Biochemistry |
| Basavapathruni A, Gureasko J, Porter Scott M, et al. (2016) Characterization of the Enzymatic Activity of SETDB1 and its 1:1 Complex with ATF7IP. Biochemistry |
| Dai H, Case AW, Riera TV, et al. (2015) Crystallographic structure of a small molecule SIRT1 activator-enzyme complex. Nature Communications. 6: 7645 |
| Jacques SL, Aquino KP, Gureasko J, et al. (2015) Abstract 97: CARM1 preferentially methylates H3R17 over H3R26 through a random kinetic mechanism Cancer Research. 75: 97-97 |
| Riera TV, Wigle TJ, Gureasko J, et al. (2015) Abstract 2144: Kinetic mechanism of the lysine methyltransferase SMYD3 using MAP3K2 protein substrate Cancer Research. 75: 2144-2144 |
| Basavapathruni A, Gureasko J, Scott MP, et al. (2015) Abstract 104: ATF7IP does not alter the substrate specificity of the lysine methyltransferase SETDB1 Cancer Research. 75: 104-104 |